跳至主要内容
临床试验/JPRN-UMIN000013079
JPRN-UMIN000013079招募中未知

A retrospective analysis of the efficacy and safety of complete surgery for advanced ovarian, fallopian tubal, primary peritneal, uterus corpus cancer - A retrospective analysis of the efficacy and safety of complete surgery for advanced ovarian, fallopian tubal, primary peritneal, uterus corpus cancer

School of Medicine, Chiba University0 个研究点目标入组 50 人开始时间: 2014年2月5日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional,observational

入排标准

年龄范围
25years-old 至 80years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1)Patients who have a history of hypersensitivity to gemcitabine and irinotecan. 2)Patients with active infection 3)Patients with severe complications (Heart disease, uncontrolleddiabetes, malignant hypertension, or bleeding tendency) 4)Patients with other cancer within the past 5 years 5)Patients with myocardial infarction within 6 months or angina attack. 6)Patients who are inappropriate to enter this study with any safety reasons,judged by the treating physician.

研究者

发起方
School of Medicine, Chiba University

相似试验